IMAX - IMAX Corporation
AMC Entertainment (NYSE:AMC) stock is up 5% to $3.16 in afternoon trading, extending a rally that began when the company first announced its refinancing. The gain comes roughly a week after that $3.
NNBR, EQNR and IMAX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 12, 2026.
EQNR, NNBR, IMAX, MCY and ROST have been added to the Zacks Rank #1 (Strong Buy) List on October 12, 2026.
IMAX Corp (NYSE:IMAX)'s position looks secure for now, according to Wedbush, which poured water on a Bloomberg report that Disney has pushed to build a competing premium screen network. According to Bloomberg, Disney has approached Skydance/Paramount Studios and Universal about forming a coalition to rival IMAX screens.
Top-ranked stocks ELF, IMAX, CBRL, FTNT and VLO are likely to beat on the bottom line in their upcoming releases.
Institutions have bought IMAX Corporation (IMAX) shares in huge ways – 47 outlier inflows since 2010.
IMAX Corporation is rated a Strong Buy, driven by record-breaking summer box office results and a unique, high-margin business model. IMAX's technology licensing, premium brand, and system sales position it to benefit from blockbuster films designed specifically for its format. The Odyssey's IMAX-exclusive production and performance signal a structural shift toward premium theatrical experiences, boosting IMAX's growth runway.
IMAX Corporation remains a Buy based on my assessment of the company's outlook after the launch of The Odyssey movie. FY2026 guidance targets a 52% worldwide box office increase and 5.6ppts EBITDA margin expansion versus the FY2024 baseline, underpinned by a more favorable mix and additional merchandising revenues. IMAX's EPS CAGR is expected to go from FY16–25's +7.9% to +19.5% for FY25-29, as the brand becomes increasingly favored by various stakeholders in the film industry.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Morgan Stanley initiated coverage on IMAX NYSE: IMAX on Sept. 24 at Overweight with a $63 price target.
iHuman (NYSE: IH - Get Free Report) and IMAX (NYSE: IMAX - Get Free Report) are both communication services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Risk and Volatility iHuman has a beta of 0.04,
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Imax (IMAX) possesses solid growth attributes, which could help it handily outperform the market.
Film and television production and distribution companies like NWSA, CNK, IMAX and CURI are thriving despite heavy spending on original programming and exclusive rights.
Movie theater stocks are selling off as a group, and shares of AMC Entertainment (NYSE:AMC) are absorbing the largest losses among the exhibitors. AMC stock is at $2.73, down 9% as the market session continues.
Selling is landing hard on AMC Entertainment (NYSE:AMC) stock as the theater chain is giving back part of a sharp rally from the prior session. AMC stock is at $3.05, down 7% in afternoon trading.
AMC Entertainment (NYSE:AMC) stock rose 13% in afternoon trading, reaching $3.32 and extending a rally that began with the company's $3.97 billion refinancing package announced last week, according to AMC Entertainment Holdings.
Meta is renewing its quest to make virtual reality a thing. At Connect on Wednesday, the company announced Meta VR Glasses, its newest entry into the VR market.
Here is how Imax (IMAX) and Madison Square Garden Entertainment (MSGE) have performed compared to their sector so far this year.
Shares of AMC Entertainment (NYSE:AMC) are climbing on Monday after the company launched a debt refinancing that pushes its nearest large maturity from 2029 out to 2031. AMC stock is up 7% to $2.